A Multi-institutional Study of Prevalence and Clinicopathologic Features of Non-invasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features (NIFTP) in Korea
Authors:
- Ja Yeong SeoJSJa Yeong Seo
- Ji Hyun ParkJPJi Hyun Park
- Ju Yeon PyoJPJu Yeon Pyo
- Yoon Jin ChaYoon Jin Cha
- Chan Kwon JungChan Kwon Jung
- Dong Eun SongDSDong Eun Song
- Jeong Ja KwakJKJeong Ja Kwak
- So Yeon ParkSPSo Yeon Park
- Hee Young NaHNHee Young Na
- Jang-Hee KimJKJang-Hee Kim
- Jae Yeon SeokJSJae Yeon Seok
- Hee Sung KimHKHee Sung Kim
Open Access
- 15 November 2019
- journal article
- research article
- Published by The Korean Society of Pathologists and The Korean Society for Cytopathology in Journal of Pathology and Translational Medicine
- Vol. 53 (6) , 378-385
Abstract
In the present multi-institutional study, the prevalence and clinicopathologic characteristics of non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) were evaluated among Korean patients who underwent thyroidectomy for papillary thyroid carcinoma (PTC). Data from 18,819 patients with PTC from eight university hospitals between January 2012 and February 2018 were retrospectively evaluated. Pathology reports of all PTCs and slides of potential NIFTP cases were reviewed. The strict criterion of no papillae was applied for the diagnosis of NIFTP. Due to assumptions regarding misclassification of NIFTP as non-PTC tumors, the lower boundary of NIFTP prevalence among PTCs was estimated. Mutational analysis for BRAF and three RAS isoforms was performed in 27 randomly selected NIFTP cases. The prevalence of NIFTP was 1.3% (238/18,819) of all PTCs when the same histologic criteria were applied for NIFTP regardless of the tumor size but decreased to 0.8% (152/18,819) when tumors ≥1 cm in size were included. The mean follow-up was 37.7 months and no patient with NIFTP had evidence of lymph node metastasis, distant metastasis, or disease recurrence during the follow-up period. A difference in prevalence of NIFTP before and after NIFTP introduction was not observed. BRAFV600E mutation was not found in NIFTP. The mutation rate for the three RAS genes was 55.6% (15/27). The low prevalence and indolent clinical outcome of NIFTP in Korea was confirmed using the largest number of cases to date. The introduction of NIFTP may have a small overall impact in Korean practice.Keywords
Funding Information
- Korean Society of Pathologists (2017-05-001)
This publication has 30 references indexed in Scilit:
- The Increase in Thyroid Cancer Incidence During the Last Four Decades Is Accompanied by a High Frequency ofBRAFMutations and a Sharp Increase inRASMutationsThe Journal of Clinical Endocrinology & Metabolism, 2014
- Follicular Variant of Papillary Thyroid Carcinoma is a Unique Clinical Entity: A Population-Based Study of 10,740 CasesThyroid®, 2013
- Detection ofBRAFV600E Mutation With Thyroid Tissue Using PyrosequencingAmerican Journal of Clinical Pathology, 2013
- Molecular genetics and diagnosis of thyroid cancerNature Reviews Endocrinology, 2011
- Encapsulated Classic and Follicular Variants of Papillary Thyroid Carcinoma: Comparative Clinicopathologic StudyEndocrine Practice, 2010
- Follicular variant of papillary thyroid carcinomaCancer, 2006
- Classical and Follicular Variant of Papillary Thyroid Carcinoma: A Comparative Study on Clinicopathologic Features and Long‐term OutcomeWorld Journal of Surgery, 2006
- Molecular Profile and Clinical-Pathologic Features of the Follicular Variant of Papillary Thyroid Carcinoma: An Unusually High Prevalence of ras MutationsAmerican Journal of Clinical Pathology, 2003
- Molecular Profile and Clinical-Pathologic Features of the Follicular Variant of Papillary Thyroid CarcinomaAmerican Journal of Clinical Pathology, 2003
- Pure versus follicular variant of papillary thyroid carcinomaCancer, 2003